XML 34 R25.htm IDEA: XBRL DOCUMENT v3.21.2

Disaggregation of Revenues and Concentration Risk (Tables)

9 Months Ended

Sep. 30, 2021

Disaggregation Of Revenues And Concentration Risk

Schedule of Consolidated Revenues Generated by Unaffiliated Customers

The following table presents the percentage of consolidated revenues generated by unaffiliated customers that individually represent greater than ten percent of consolidated revenues:

 Schedule of Consolidated Revenues Generated by Unaffiliated Customers

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2021				2020				2021				2020
Medicare for DetermaRx			23	%			35	%			23	%			27	%
Medicare Advantage for DetermaRx			16	%			0*				17	%			0*
Pharma services Company A			0*				0*				0*				21	%
Pharma services Company B			0*				28	%			0*				22	%
Pharma services Other			26	%			26	%			11	%			27	%
Licensing - Company D			0*				0*				25	%			0*
Licensing - Company B			26	%			0*				12	%			0*

* Less than 10%

Schedule of Consolidated Revenues Attributable to Products or Services

The following table presents the percentage of consolidated revenues by products or services classes:

 Schedule of Consolidated Revenues Attributable to Products or Services

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2021				2020				2021				2020
DetermaRx			41	%			37	%			40	%			31	%
Pharma Services			29	%			63	%			23	%			69	%
Licensing			30	%			-				37	%			-
Total			100	%			100	%			100	%			100	%

Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations

The following table presents the percentage of consolidated revenues attributable to geographical locations:

 Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2021				2020				2021				2020
United States			61	%			63	%			41	%			56	%
Outside of the United States – Pharma Services			9	%			37	%			22	%			44	%
Outside of the United States – Licensing			30	%			-				37	%			-
Total			100	%			100	%			100	%			100	%

Schedule of Accounts Receivable from Third Party and Other Customers

The following table presents Oncocyte’s total accounts receivable from third-party payers and other customers at September 30, 2021 and December 31, 2021.

 Schedule of Accounts Receivable from Third Party and Other Customers

		September 30, 2021				December 31, 2020
Medicare for DetermaRx™		$	148			$	91
Medicare Advantage for DetermaRx™			597				-
Pharma Services and other			287				112
Total		$	1,032			$	203

Schedule of Percentage of Total Consolidated Accounts Receivables

The following table presents accounts receivable, as a percentage of total consolidated accounts receivables, from third-party payers and other customers that provided in excess of 10% of Oncocyte’s total accounts receivable.

 Schedule of Percentage of Total Consolidated Accounts Receivables

		September 30, 2021				December 31, 2020
Medicare for DetermaRx™			14	%			45	%
Medicare Advantage for DetermaRx™			58	%			*
Pharma Services Company A			*				35	%

X

- References

No definition available.

+ Details

Name:	OCX_DisclosureDisaggregationOfRevenuesAndConcentrationRiskAbstract
Namespace Prefix:	OCX_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Consolidated Revenues Attributable to Products or Services [Table Text Block]

+ References

No definition available.

+ Details

Name:	OCX_ScheduleOfConsolidatedRevenuesAttributableToProductsOrServicesTableTextBlock
Namespace Prefix:	OCX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Consolidated Revenues Generated by Unaffiliated Customers [Table Text Block]

+ References

No definition available.

+ Details

Name:	OCX_ScheduleOfConsolidatedRevenuesGeneratedByUnaffiliatedCustomersTableTextBlock
Namespace Prefix:	OCX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Percentage of Total Consolidated Accounts Receivables [Table Text Block]

+ References

No definition available.

+ Details

Name:	OCX_ScheduleOfPercentageOfTotalConsolidatedAccountsReceivablesTableTextBlock
Namespace Prefix:	OCX_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allowance for credit loss on accounts receivable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447

+ Details

Name:	us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration